• 1
    Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG: Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970–1991. Arthritis Rheum 38: 369373, 1995
  • 2
    Melton LJ: History of the Rochester Epidemiology Project. Mayo Clinic Proc 71: 266274, 1996
  • 3
    Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG: The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med 123: 192194, 1995
  • 4
    Melton LJ III: Epidemiology of fractures. Second edition. Philadelphia, Lippincott-Raven Publishers, 1995
  • 5
    Cooper C, Atkinson EJ, Kotowicz M, O'Fallon WM, Melton LJ III: Secular trends in the incidence of postmenopausal vertebral fractures. Calcif Tissue Int 51: 100104, 1992
  • 6
    Palumbo PJ, Labarthe DR: The incidence of diabetes mellitus in Rochester, Minnesota, 1945–1969. Adv Metab Dis 9: 1328, 1978
  • 7
    Madhok R, Melton LJ III, Atkinson EJ, O'Fallon WM, Lewallen DG: Urban vs rural increase in hip fracture incidence: age and sex of 901 cases 1980–89 in Olmsted County, U.S.A. Acta Orthop Scand 64: 543548, 1993
  • 8
    Cooper C, Atkinson EJ, O'Fallon WM, Melton LJ III: Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985–1989. J Bone Miner Res 7: 221227, 1996
  • 9
    Saag KG, Koehnke R, Caldwell JR, Brasington R, Burmeister LF, Zimmerman B, Kohler JA, Furst DE: Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med 96: 115123, 1994
  • 10
    Michel BA, Bloch DA, Wolfe F, Fries JF: Fractures in rheumatoid arthritis: an evaluation of associated risk factors. J Rheumatol 20: 16661669, 1993
  • 11
    Nesher G, Sonnenblick M, Friedlander Y: Analysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of 43 patients. J Rheumatol 21: 12831286, 1994
  • 12
    Mateo L, Nolla JM, Rozadilla A, Rodriguez-Moreno JR. Niubo R, Valverde J, Roig-Escofet D: Bone mineral density in patients with temporal arteritis and polymyalgia rheumatica. J Rheumatol 20: 13691373, 1993
  • 13
    Kirwan JR: The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 333: 142146, 1995
  • 14
    Saag KG, Criswell LA, Sems KM, Nettleman MD, Kolluri S: Lowdose corticosteroids in rheumatoid arthritis: a meta-analysis of their moderate-term effectiveness. Arthritis Rheum 39: 18181825, 1996
  • 15
    Ramos-Remus C, Sibley J, Russell AS: Steroids in rheumatoid arthritis: the honeymoon revisited. J Rheumatol 19: 667670, 1992
  • 16
    Criswell LA, Redfearn WJ: Variation among rheumatologists in the use of prednisone and second-line agents for the treatment of rheumatoid arthritis. Arthritis Rheum 37: 476480, 1994
  • 17
    American College of Rheumatology Task Force on Osteoporosis Guidelines: Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 39: 17911801, 1996